Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.91% |
| 2 | Financials | 6.05% |
| 3 | Healthcare | 5.04% |
| 4 | Consumer Discretionary | 4.86% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
EPR Properties
EPR
$4.64B
| $3.7M | ﹤0.01% |
134,510
+50,173
| +59% | +$1.57M |
|
1602
Kura Oncology
KURA
$887M
| $3.68M | ﹤0.01% |
120,146
+34,868
| +41% | +$770K |
|
1603
WD-40
WDFC
$3.13B
| $3.68M | ﹤0.01% |
19,453
+6,789
| +54% | +$1.33M |
|
1604
PUT
Kohl's
KSS
$2.14B
| $3.68M | ﹤0.01% |
198,600
-33,300
| -14% | -$705K |
|
1605
Cheesecake Factory
CAKE
$5.81B
| $3.67M | ﹤0.01% |
132,430
-20,289
| -13% | -$532K |
|
1606
Werner Enterprises
WERN
$2.26B
| $3.67M | ﹤0.01% |
87,428
-17,030
| -16% | -$754K |
|
|
ITCI
1607
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.67M | ﹤0.01% |
143,116
+52,394
| +58% | +$1.2M |
|
1608
Graco
GGG
$13.4B
| $3.66M | ﹤0.01% |
59,692
+32,141
| +117% | +$1.8M |
|
1609
Iridium Communications
IRDM
$5.26B
| $3.65M | ﹤0.01% |
142,680
+39,809
| +39% | +$1.1M |
|
1610
CALL
BlackBerry
BB
$5.22B
| $3.65M | ﹤0.01% |
794,300
| – | – |
|
1611
CALL
VanEck Semiconductor ETF
SMH
$72.4B
| $3.64M | ﹤0.01% |
41,800
| – | – |
|
1612
CALL
Accenture
ACN
$109B
| $3.64M | ﹤0.01% |
16,100
-7,100
| -31% | -$1.63M |
|
|
SAFM
1613
DELISTED
Sanderson Farms Inc
SAFM
| $3.63M | ﹤0.01% |
30,819
-2,041
| -6% | -$239K |
|
1614
Stepan Co
SCL
$1.47B
| $3.63M | ﹤0.01% |
33,309
+7,792
| +31% | +$853K |
|
1615
ESCO Technologies
ESE
$7.77B
| $3.63M | ﹤0.01% |
45,026
+5,980
| +15% | +$516K |
|
|
TIF
1616
CALL
DELISTED
Tiffany & Co.
TIF
| $3.62M | ﹤0.01% |
31,200
+4,700
| +18% | +$571K |
|
1617
Alarm.com
ALRM
$2.73B
| $3.61M | ﹤0.01% |
65,293
+20,725
| +47% | +$1.28M |
|
|
LTC
1618
LTC Properties
LTC
$2.08B
| $3.6M | ﹤0.01% |
103,281
+3,696
| +4% | +$136K |
|
1619
Avista
AVA
$3.22B
| $3.6M | ﹤0.01% |
105,447
+35,183
| +50% | +$1.27M |
|
1620
Ionis Pharmaceuticals
IONS
$9.43B
| $3.6M | ﹤0.01% |
75,847
-3,954
| -5% | -$220K |
|
|
HR
1621
DELISTED
Healthcare Realty Trust Incorporated
HR
| $3.59M | ﹤0.01% |
119,233
-40,594
| -25% | -$1.17M |
|
|
GWPH
1622
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.58M | ﹤0.01% |
36,820
+16,738
| +83% | +$1.93M |
|
1623
PUT
Regeneron Pharmaceuticals
REGN
$81.9B
| $3.58M | ﹤0.01% |
6,400
-2,200
| -26% | -$1.33M |
|
1624
Gold Fields
GFI
$36.4B
| $3.57M | ﹤0.01% |
290,874
-119,251
| -29% | -$1.47M |
|
1625
Brixmor Property Group
BRX
$9.09B
| $3.57M | ﹤0.01% |
305,523
-104,230
| -25% | -$1.26M |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.